SteriPack Group Elevates Pharma Sector Final Assembly Services with Strategic Partnership with SHL Medical

STP SHL Announcement

Expanding the Molly® autoinjector platform final assembly and secondary packing capabilities in Europe for complex small to mid-sized volumes.

DUBLIN, IRELAND – January 22nd 2024 SteriPack Group (“SteriPack”), a leading contract packing organisation serving the pharmaceutical industry, today announced a strategic partnership with SHL Medical (“SHL”), a world-leading provider of advanced drug delivery systems. The partnership will establish a pre-validated, highly flexible final assembly and secondary packing service at the SteriPack facility in Poland for SHL’s second-generation Molly® 1.0ml autoinjector platform, adding to its small to mid-volume offering in Europe.

The collaboration between SteriPack and SHL Medical leverages the strengths of both organisations to provide high-quality final assembly and contract packing options for pharmaceutical companies seeking expert support with the complex localisation often associated with small to mid-sized volumes of targeted, self-administered drugs.

This latest alliance adds to SteriPack’s growing portfolio of global autoinjector platform partners. The partnership is testament to SteriPack’s experience devising highly tailored solutions using its specialist equipment and tooling, and the value the company places on flexibility and time-to-market for project launches.

SHL and its customers can now benefit from SteriPack’s customer-centric final assembly and secondary packing solutions offering the highest service standards, industry-leading timelines, stability and supply chain efficiency.

Markus Puusepp, SHL Medical’s Chief Growth Officer, expressed his enthusiasm about the partnership, stating “This partnership is a significant addition to the Molly® platform value proposition. We share common values with SteriPack, from focus on the customer to a commitment to quality, making the decision to collaborate straightforward.”

John Ward, SteriPack Group’s VP Pharmaceutical Solutions commented ”SteriPack Group looks forward to supporting SHL Medical and their customers in providing quality and flexible solutions to a fast-moving market. With an emphasis on creating service solutions designed around specific customer requirements, this partnership will make the process of working with the Molly® platform an easy decision.”

For more information on this announcement, join us at Booth #H100, Hall 7.2 at Pharmapack, Paris, 24-25 January 2024. 

Contact information

Media contact

Artur Jankowski

Marketing Manager

[email protected]

+48 502 358 519 

Alliance management contact

Marta Karwan

Sales and Marketing Director

[email protected]

+48 510 066 500 

Media contact

Carl Gillblad 

Communications and Marketing Operations

[email protected]

+41 41 368 00 00

Alliance management contact 

Alina Smotrova  

Corporate Development  

[email protected]

+41 41 368 00 00

About SteriPack Group 

SteriPack Group is a globally renowned contract packing and manufacturing organisation serving the pharmaceutical and medical device sectors respectively. With a strong emphasis on innovation, quality and compliance, SteriPack‘s services to the pharmaceutical industry include device design and development, final assembly, labelling, secondary packing, serialisation and aggregation of injectable formats including vials, pre-filled syringes, and autoinjectors.

SteriPack‘s tailored customer-focused solutions make it an ideally suited supplier for small to medium-sized batch volumes required for a growing market of targeted therapies as well as clinical trials. Its proven capabilities in cleanroom assembly and labelling as well as secondary packing services for drug delivery systems and medical devices, combined with significant investment into growing cold chain storage capacity, have helped to make it a trusted partner to top global pharmaceutical companies.

About SHL Medical 

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by its company purpose – Enabling Patients’ Independence – SHL Medical offers patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. It also offers final assembly, labeling, and packaging solutions for its drug delivery systems.   

In response to the rising trend in home therapy, SHL Medical has increased its developmental work in the digital healthcare sector to help improve the drug delivery ecosystem.  

Located across Switzerland, Taiwan, Sweden, and the US, SHL Medical’s global team of experts collaborate seamlessly as one team in utilizing its comprehensive in-house manufacturing capabilities. Its solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into its designs and processes to contribute to a cleaner earth.

For additional information, visit www.shl-medical.com.